Nearly 10 million newborns are screened with Victor™ 2D each year. The
semi-automated system is a robust, cost-efficient solution for screening of seven NBS
disorders: congenital hypothyroidism, phenylketonuria, congenital adrenal hyperplasia,
galactosemia, cystic fibrosis, biotinidase deficiency and G6PD deficiency.
- Easy to use and reliable measurement device
- Preset protocols for neonatal assays based on time-resolved fluorescence (TSH, T4, 17-OHP, IRT) or prompt fluorescence (PKU, GALT, TGAL, BTD, G6PD)
- MultiCalc software included for result calculation
- QC control and communication with LIMS